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TCTAP A-026
The Angiotensin Converting Enzyme-2 Local Activated in Infarct-Related
Coronary Accelerated Myocardial Reverse Remodeling After Myocardial
Infarction
Luan Bo,1 Guo Peng1
1The People’s Hospital of Liaoning Province, China
BACKGROUND Growing evidence exists for local Angiotensin Con-
verting Enzyme-2 (ACE2) can be highly activated independent, which
is little affected by circulation renin-angiotensin system (RAS). But
there is rare information about changes in ACE2 activity in acute
myocardial infarction and in reverse remodeling.
METHODS All patients admitted with acute myocardial infarction (n ¼
20), were under urgent percutaneous coronary intervention therapy.
Biochemical markers (rein、ACE1、ACE2 and aldosterone activity)
were detected, which were from vein, femoral artery and Infarct-
related coronary. All patients were arranged with cardiac magnetic
resonance (CMR) and routine echocardiography. CMR and echocar-
diographic parameters (EF, left ventricular end-diastolic (EDD) and
end-systolic diameter (ESD)) were measured. Routine ACEIs were
given to all the patients.
RESULTS Coronary’s local ACE2 level were highly activated compared
to the circulation\’s, but not observed in rein、ACE1 and aldosterone
level. Furthermore, the coronary\’s local ACE2 level can\’t be inhibi-
ted by ACEIs (two weeks). The local ACE2 activity negatively corre-
lated with EF and positively with ESD and EDD in all patients’
populations. And then local ACE2 activities especially increased in
patients with deﬁnitive heart failure, meanwhile the ﬁbrosis or scar-
ring within infarcted myocardium aggravated with the local
increasing ACE2 level detected by CMR.
CONCLUSION The local ACE2 activity appeared to be new biomarker
in heart reverse remodeling, whereas heart failure might be immi-
nent by the high local ACE2 levels, which cannot be decreased by
ACEIs. Our data suggested that local ACE2 but not RASS was
involved in the pathomechanism of heart failure in short term after
infarction. The new target drug of inhibition of local ACE2 will be
issued in the future.
TCTAP A-027
Panax Notoginseng Saponins Safely Boost Cardiac Function and Anti-
apoptosis in a Myocardial Infarction Model in the Rat via the MEK/ERK
Pathway
Caixia Guo,1 Lihong Ma1
1Fuwai Hospital, China
BACKGROUND Panax notoginseng saponins (PNS) are one of the
most important compounds derived from roots of the herb Panax
notoginseng which are frequently used in the area of cardiovascular
protection. Meanwhile, anti-apoptosis offers the potential for treat-
ing ischemic cardiomyopathy. The aim of this study was to examine
whether PNS can boost cardiac function and anti-apoptosis after
myocardial infarction and to determine the role of MEK/ERK
pathway.
METHODS A month after left anterior descending coronary artery
ligation, rats received either intraperitoneal injection of PNS, or the
same volume of saline. Cardiacfunction was assessed echocardio-
graphically, and anti-apoptosis was assessed by western blot four
weeks after therapy.
RESULTS Reductions in infarction area and scar collagen content
were observed by improvements in left ventricular function and
attenuation of left ventricle remodeling that were observed histolog-
ically in the infarct region compared with the saline control. Echo-
cardiography also showed signiﬁcant improvements in ejection
fraction and fractional shortening in the PNS group. Meanwhile, PNS
signiﬁcantly decreased apoptosis relative to control group, evidenced
by inﬂuencing the expression ofbcl-2、bax、cytochromC and cas-
pase3 in the infarctive myocardial. Furthermore, the phosphorylation
of MEK/ERK was decreased after the treatment with PNS.
CONCLUSION In conclusion, these results show for the ﬁrst time
that PNS can decrease apoptosis and preserve cardiac function at
least in part through the MEK/ERK pathway, which provides a
novel explanation for the multi-function of PNS on cardiovascular
system.TCTAP A-028
Adiponectin Ameliorates Angiotensin II-Induced Vascular Endothelial
Damage
Zhi Zuo,1 Pengfei Zuo,1 Genshan Ma1
1Zhong Da Hospital, Southeast University, China
BACKGROUND Adiponectin is an adipocyte-speciﬁc adipocytokine that
has been shown to have a beneﬁcial effect on the cardiovascular system,
but it remains tobeelucidatedwhether adiponectinhasa therapeutic effect
on vascular damage induced by the potential vasoactive substance
Angiotensin II (Ang II). In this study, the effects of adiponectin on Ang II-
induced vascular endothelial damage were investigated.
METHODS In cultured human umbilical vein endothelial cells (HUVECs)
stimulated with Ang II, levels of ROS and 4-hydroxy-2-nonenal (4-HNE)
were measured. MTT reduction assay was used to determine cell
viability. TUNEL assay and DAPI staining were used to determine
HUVECs apoptosis. The expression of LOX-1 was quantitative analyzed by
immunoblots method. We knocked down expression of AdipoR1 and
AdipoR2 by RNA interference in HUVECs in aim to research the pathway
in which d a role. APPL1 and AMPL expression were also knocked down.
RESULTS In HUVECs, AngII stimulation increased generation of ROS
and 4-HNE, both of which were clearly restored by administration of
adiponectin. In addition, adiponectin was found to increase cell
viability and prevent apoptosis (Figure 1). It’s demonstrated that the
protective effects of adiponectin are dependent on the binding of its cell
surface receptor 1 (Figure 2). Importantly, we found that adiponectin
treatmentmodulates the apoptotic pathwayby reducing the expression
of LOX-1,up-regulating both cIAP-1 and the ratio of Bcl-2/Bax. Finally,
our data displayed that the protective effects of adiponectin against
Ang II cytotoxicity depend on AMPK activation mediated by the endo-
somal adaptor protein APPL1 (Figure 3).
